Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can two therapies together beat tennis elbow?

NCT ID NCT07782723

Symptom relief Sponsor: Ankara Yildirim Beyazıt University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This trial tests whether adding blood flow restriction therapy to standard shock wave therapy improves pain, grip strength, and arm function in people with lateral epicondylitis, commonly known as tennis elbow. Participants receive either the combined treatment or shock wave therapy alone over four weekly sessions. The study measures pain, strength, and daily function before and after treatment to see if the combination offers extra benefits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Blood flow restriction therapy combined with extracorporeal shock wave therapy
What this could lead to
If effective, this combination could offer a new, non-surgical treatment protocol to reduce pain and improve function in people with tennis elbow.
What could go wrong
This is a small, early-stage trial with only 52 participants, so results may not apply broadly. The added benefit of combining the two therapies is unproven, and individual responses may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 52 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Having been diagnosed with lateral epicondylitis by a specialist physician 2. Being between the ages of 18 and 60 3. Having a body mass index (BMI) between normal weight (18.5-24.9 kg/m²) and overweight (25.0-29.9 kg/m²) 4. Volunteering to participate in the study Exclusion Criteria: 1. Presence of a different elbow pathology 2. Presence of bilateral lateral epicondylitis 3. Presence of sensory and motor impairments in the upper extremities 4. History of surgery in the elbow region 5. History of systemic or metabolic disease 6. History of diabetes mellitus 7. History of hematological disease 8. History of cardiac disease, heart failure, or coronary artery disease 9. History of hypertension 10. Malignancy 11. History of peripheral vascular disease (presence of varicose veins/history, history of deep vein thrombosis, presence of lymphedema) 12. Coagulation disorder 13. Use of anticoagulants 14. History of pulmonary disease 15. History of pulmonary embolism 16. Pregnancy 17. Use of oral contraceptives 18. Patients with a pacemaker 19. History of trauma to the upper extremity within the past 6 months or 1 year

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lateral epicondylitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epicondylitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lateral epicondylitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Gülhane Training and Research Hospital, Clinic of Sports Medicine

    RECRUITING

    Ankara, 06010, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.